Company Overview

Development Stage

About the Company

[Summary] National Innovative Demonstration Enterprise for Pharmaceutical Distri

Ruikang Pharmaceutical Group Co., Ltd. was established on September 21, 2004, with its registered address in Yantai City, Shandong Province, and its management headquarters in Beijing. The registered capital is 1.5 billion yuan, and it has more than 12,000 employees. It was listed on the Shenzhen A-share market in June 2011. Currently, Ruikang Pharmaceutical has grown into a comprehensive service provider that directly distributes pharmaceuticals, medical devices, and medical consumables to medical institutions nationwide, while also offering medical informatization services, hospital management consulting services, in-hospital logistics services, and hospital support services. It is a leading enterprise in the national pharmaceutical and medical device distribution industry, with a sales network covering the entire country, directly serving more than 8,000 medical institutions above the second level and more than 33,500 primary medical institutions nationwide. It currently has more than 240 subsidiaries across 31 provinces.
In 2017, Ruikang Pharmaceutical's sales revenue exceeded 27 billion yuan, with profits exceeding 1 billion yuan and tax payments reaching 1.15 billion yuan, ranking 316th in the Fortune China 500. The company's operating revenue and profits have grown at a rate exceeding 50% for three consecutive years. Its ranking among the top 100 pharmaceutical commercial enterprises in China has risen from 38th in 2010 to 10th in 2017. It is expected to achieve sales revenue of 40 billion yuan in 2018, striving to enter the top 6 of the national top 100 pharmaceutical commercial enterprises.
With six major combat zones domestically and eighteen product lines, we have been well-prepared and ready to seize opportunities. Staying true to our original aspiration and acting with kindness, becoming the best partner for medical institutions and the leading enterprise in the healthcare industry are our eternal goals.
As a pharmaceutical distribution enterprise, the company currently ranks 6th to 7th nationally and first among private enterprises. It is a typical private enterprise currently undergoing transformation. The earlier full implementation of the SAP module has laid a solid foundation, leaving ample room for development.
Compensation is open, and the company has long-term guidance from internationally renowned consulting firms.
The company is transitioning from a business-oriented to a management-oriented model, shifting toward standardization, transparency, and a technology-driven enterprise.

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

Ruikang Pharmaceutical Financing History (2 rounds)

Manage
IPO上市
Capital Market Favor
Latest Financing Round
  • Date: ?
  • Market: 主板
  • Deal: 深交所

Ruikang Pharmaceutical How Fast Is Hiring Growing? (74 open positions)

Manage
Note: How fast is hiring at Ruikang Pharmaceutical Group Co., Ltd. growing? Ruikang Pharmaceutical2025: 334 openings (up 96%), 2024: 170 openings (up 83%), 2023: 93 openings (up 4%), 2022: 89 openings (down 56%), 2021: 200 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

Ruikang Pharmaceutical Master's Degree Job Demand Analysis

(More)
?
Growth Rate
2026 vs 2025
  • 2025: Up 250%
  • 2024: Down 33%
  • 2023: Flat 0%-
  • 2022: Down 25%
Ruikang Pharmaceutical Master's Hiring by Year:
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is master's hiring at Ruikang Pharmaceutical Group Co., Ltd. growing? Ruikang PharmaceuticalMaster's recruitment over the years: 2025: 7 openings (up 250%), 2024: 2 openings (down 33%), 2023: 3 openings (flat), 2022: 3 openings (down 25%), 2021: 4 openings.

Ruikang Pharmaceutical Doctoral Degree Job Demand Analysis

(More)
N/A
Growth Rate
Ruikang Pharmaceutical Doctoral Hiring by Year: 2026
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is doctoral hiring at Ruikang Pharmaceutical Group Co., Ltd. growing? Ruikang PharmaceuticalDoctorate recruitment over the years: 2026: 1 openings (flat), 2024: 1 openings (down 33%).

Ruikang Pharmaceutical R&D Strength (Technical Talent Demand)

(More)
How is the demand for technical talent at Ruikang Pharmaceutical Group Co., Ltd.? Based on an analysis of Ruikang Pharmaceutical's job postings over the past year, "医疗卫生/美容保健类" demand: 25.4%, "计算机/网络/技术类": 14%, "其他(研发和技术类)": 2.2%, "生物/制药/化工/环保类": 1.6%, "电气/能源/动力类": 0.6%, "咨询/顾问类": 0.3%. For reference only.

Ruikang Pharmaceutical — What Are the Salaries Like? (315 records)

Manage
Ruikang Pharmaceutical Salary Overview
salary range: 4.5K - 50K, 63.1% of roles pay ¥6-15K
Note: salary statistics are based on 315 salary records from the past year and depend on the job sample. For reference only.
How is the salary at Ruikang Pharmaceutical Group Co., Ltd.?Ruikang Pharmaceutical63.1% of positions earn 6-15K, Fresh graduate salary: ¥5.3K。Yantai salary ranking top 35,销售类 average salary ¥10.4K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Salaries for hot jobs of Ruikang Pharmaceutical

(More)
Are salaries high at Ruikang Pharmaceutical Group Co., Ltd.? We provide: 医药代表,销售,学术专员,药学,业务员,推广,采购,市场,理赔,会计,文员,内勤,审核,开发工程师,财务,前端,地区经理,java,信息,医疗器械. Click to view detailed salary analysis by job.

Ruikang Pharmaceutical — Fortune 500? (More)

Ruikang Pharmaceutical honors, qualifications & industry associations

Tags are labelled based on keyword text matching analysis and may be related to the company. For reference only.

Ruikang Pharmaceutical Related Industry Tags

Job Category

  • 销售类
    44.8% of total 44.8%
  • 医疗卫生/美容保健类
    25.4% of total 25.4%
  • 计算机/网络/技术类
    14% of total 14%
  • 经营管理类
    13% of total 13%

Education

  • 本科
    50.5% of total 50.5%
  • 大专
    43.5% of total 43.5%
  • 硕士
    2.5% of total 2.5%
  • 高中
    1.6% of total 1.6%

Experience

  • 1-3年
    41% of total 41%
  • 3-5年
    25.4% of total 25.4%
  • 不限
    22.9% of total 22.9%
  • 5-10年
    10.5% of total 10.5%
View Detailed Analysis

What does Ruikang Pharmaceutical Group Co., Ltd. require? Who is Ruikang Pharmaceutical hiring? Ruikang Pharmaceutical recruitment: 销售类占比最多占44.8%,其次是医疗卫生/美容保健类占25.4%. What education can get in at Ruikang Pharmaceutical? 本科占比最多占50.5%,其次是大专占43.5%. High education required at Ruikang Pharmaceutical? 硕士占2.5%,博士占0.3%. Work experience required at Ruikang Pharmaceutical? 1-3年占比最多占41%,其次是3-5年占25.4%. Where are the job locations at Ruikang Pharmaceutical? 济南占比最多占15.9%,其次是烟台占13.3%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 150,471.0471万(元)
Legal Representative: 韩旭
Date Established:
Credit Code: 91370000766690447B
Registered Address: 山东省烟台市芝罘区凤鸣路103号13号楼

Partners & Suppliers

为济南北城医院提供药品配送服务 Source
合作客户 药品配送
河南科伦药业有限公司通过瑞康医药向医院配送输液产品 Source
供应商 医药商业-配送
瑞康医药为国大药房在山东的门店供应药品 Source
合作客户 药品零售客户
瑞康医药通过分销体系为益丰大药房提供药品 Source
合作客户 药品零售客户
瑞康医药为漱玉平民大药房提供药品配送服务,覆盖其山东门店 Source
合作客户 药品零售客户

People who follow Ruikang Pharmaceutical also follow

Ruikang Pharmaceutical Competitors (Similar Companies)

“Customer-oriented, Efficient operations, Empower employees”
“A modern pharmaceutical enterprise spanning three major fields: modern”
“Caring for life, safeguarding health”
“Energy management system solution provider”
“Research, development, and production of anti-tumor and surgical medic”
“Adhering to the corporate culture of science and excellence, committed”
“Large-scale pharmaceutical distribution enterprise”
制药/药业 中药提取 医药 中成药
“生化原料药生产”
“To develop high-quality biologics that are accessible and affordable f”
“A large private modern pharmaceutical distribution enterprise in China”
制药/药业 抗肿瘤药 肿瘤检测 神经系统疾病药物
“Research and development of new drugs for major diseases such as malig”
医疗大数据 数据中心/IDC 国有资本 数据中台
“从事生物药物研究开发生产的CDMO公司”

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates